Icon

TAUKLARIFY (NDA220496)- (1-40mCi/ML)

FLORQUINITAU F-18 CERVEAU LANTHEUS
1-40mCi/ML
No No
2035-Jun-09 2031-Aug-13
None None
None No
TAUKLARIFY is a radioactive diagnostic drug indicated for positron emission tomography (PET) of the brain in adults with cognitive impairment who are being evaluated for Alzheimer’s disease to identify patients with tau neurofibrillary tangle (NFT) pathology.
0 0 0
Total Other Developers None
Drugs with Suitability No
1-40mCi/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.